Results 181 to 190 of about 49,698 (296)

Olig2‐specific loss‐of‐function Slc35a2 results in hypomyelination and spontaneous seizures

open access: yesEpilepsia, EarlyView.
Abstract Objective Malformations of cortical development represent major causes of drug‐resistant epilepsy, with mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy recognized as a distinct pathological entity. Pathogenic X‐linked SLC35A2, encoding the uridine diphosphate–galactose transporter, has been implicated ...
Tiffany M. Bartel   +6 more
wiley   +1 more source

Development of a novel elastase-induced saccular aneurysm model in rats suitable for testing endovascular devices: An experimental animal study. [PDF]

open access: yesInterv Neuroradiol
Ueki Y   +8 more
europepmc   +1 more source

Meta‐analysis of genetic mapping studies in mice reveals candidate epilepsy modifier genes that are outside the current drug development landscape

open access: yesEpilepsia, EarlyView.
Abstract Objective Despite decades of development in anti‐seizure medications, ~30% of individuals remain refractory to all treatments, and none of the existing therapies are disease modifying. Identifying targets outside the current preclinical paradigm is critically important.
Giovanna L. Durante   +4 more
wiley   +1 more source

Network architecture associated with the highly specialized hindlimb of frogs

open access: gold, 2017
Daniel Andrés Dos Santos   +3 more
openalex   +2 more sources

Acute neurologic presentation of a 2‐year‐old standardbred colt with multicentric diffuse large B cell lymphoma

open access: yesEquine Veterinary Education, EarlyView.
Summary Lymphoma in horses is uncommon and rarely diagnosed as a cause of ataxia. This case report describes a 2‐year‐old Standardbred cryptorchid colt who presented with acute onset of grade 3–4/5 spinal ataxia in all four limbs, with the hindlimbs more severely affected than forelimbs and severe proprioceptive deficits.
K. MacMillan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy